← Back to Search

7T MRI for Studying Addiction

Led By Reza Momenan, Ph.D.
Research Sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between 18-65 years of age
Be older than 18 years old
Must not have
Are currently receiving psychotropic medication
Inpatients only: Currently experiencing symptoms of withdrawal from alcohol (As determined by the most recent measurement within the past 30 days CIWA score > 8)
Screening 3 weeks
Treatment Varies
Follow Up ongoing
Awards & highlights


This trial is looking for healthy right-handed volunteers 18-65 years old to help develop tasks that investigate a person's behavior.

Who is the study for?
This trial is for right-handed adults aged 18-65 who are physically healthy. It's specifically for inpatients from another study and also seeks healthy volunteers. People with metal implants, pregnant individuals, those with claustrophobia or left-handedness cannot participate.Check my eligibility
What is being tested?
The study is testing new computerized tasks to understand the behavior of people with alcohol use disorders. These tasks will be performed during a one-hour MRI scan session which may require lying still for up to 20 minutes.See study design
What are the potential side effects?
Possible side effects include discomfort from loud noises (despite earplugs), having to lie still inside the scanner which could cause stiffness or soreness, and potential anxiety due to confinement in the MRI cylinder.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I am between 18 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
I am currently taking medication for my mental health.
I am in the hospital and experiencing alcohol withdrawal symptoms.
I do not have any metal implants or fragments in my body.
I have failed a neuromotor exam.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~ongoing
This trial's timeline: 3 weeks for screening, Varies for treatment, and ongoing for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
outcome is to develop and examine tasks that reliably measure specific cognitive, motivational and decision-making behaviors

Trial Design

2Treatment groups
Experimental Treatment
Group I: 2Experimental Treatment1 Intervention
People without alcohol use disorder
Group II: 1Experimental Treatment1 Intervention
People with alcohol use disorder
First Studied
Drug Approval Stage
How many patients have taken this drug

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)Lead Sponsor
815 Previous Clinical Trials
1,159,471 Total Patients Enrolled
428 Trials studying Alcoholism
777,899 Patients Enrolled for Alcoholism
Reza Momenan, Ph.D.Principal InvestigatorNational Institute on Alcohol Abuse and Alcoholism (NIAAA)
9 Previous Clinical Trials
4,807 Total Patients Enrolled
8 Trials studying Alcoholism
4,773 Patients Enrolled for Alcoholism

Media Library

7T MRI Clinical Trial Eligibility Overview. Trial Name: NCT02108054 — N/A
Alcoholism Research Study Groups: 1, 2
Alcoholism Clinical Trial 2023: 7T MRI Highlights & Side Effects. Trial Name: NCT02108054 — N/A
7T MRI 2023 Treatment Timeline for Medical Study. Trial Name: NCT02108054 — N/A
~49 spots leftby Dec 2025